Tonix Pharmaceuticals’ CEO reveals next-generation COVID vaccine technology chosen for key program
–News Direct– Tonix Pharmaceuticals CEO Dr Seth Lederman recently joined Steve Darling from Proactive to share exciting news about their COVID vaccine, TNX-1800, selected for testing in Project Next Gen, … Read More